title: When should neuroprotective drugs move from mice to men?
authors.affiliation: Banner Alzheimer's Institute, 901 E Willetta Street, Phoenix, AZ 85006, USA. Electronic address: pierre.tariot@bannerhealth.com.
authors.forename: Pierre N
authors.initials: PN
authors.lastname: Tariot
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D013494:Supranuclear Palsy, Progressive / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D009842:Oligopeptides; C425904:davunetide